NCT02233686View on ClinicalTrials.gov

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

XEN-D0501

DRUG

Placebo

Trial Locations (1)

M23 9QZ

Medicines Evaluation Unit, Manchester

Sponsors

Collaborators (1)

Ario Pharma Ltd
All Listed Sponsors
collaborator

Ario Pharma Ltd

INDUSTRY

lead

Xention Ltd

INDUSTRY

NCT02233686 - A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD | Biotech Hunter | Biotech Hunter